The ASCO-ONS standards for administration of antineoplastic therapy provide a comprehensive framework for ensuring patient ...
Researchers estimated worldwide epidemiological trends in melanoma from 1990 to 2021, including incidence, mortality, and disability adjusted life years.
Chemotherapy was associated with short-term cognitive dysfunction after treatment completion among patients with breast cancer. These findings were published in The Oncologist. Chemotherapy-induced ...
Reports of supply chain issues less likely to be linked to drug shortages in Canada than U.S., with findings consistent before and after pandemic.
Cancer patients who received psilocybin-assisted psychotherapy experienced improvements in anxiety, depression, interpersonal sensitivity, hostility, obsession-compulsion, and somatization. Psilocybin ...
Patients with abnormal numbers of CD3 + T cells had considerably higher mortality and recurrence rates. The immune system and especially the B cells of patients with acute lymphoblastic leukemia (ALL) ...
Evidence suggests that combining metformin with standard of care could increase survival and offer other benefits to patients with high-volume disease.
Researchers sought to determine the effects of multidisciplinary team-style continuity of care with nutritional nursing in patients with lung cancer receiving postoperative chemotherapy.
Researchers sought to determine whether DNA methylation markers could be helpful in risk stratification for patients with AML and normal cytogenetics.
An intervention reduced the percentage of prior authorizations that were delayed or denied from 32% to 8%. A multi-pronged intervention reduced prior authorization delays and denials for patients ...
Findings seen in combination with chemotherapy following surgery in patients with curative intent. HealthDay News — Pembrolizumab plus chemotherapy improves disease-free survival (DFS) in ...
In a prospective longitudinal trial, researchers assessed the association between academic readiness and outcomes in patients who received brain tumor treatment in early childhood.